Ilan Ganot - 27 Jan 2022 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Role
CEO & President, Director
Signature
/s/ Erin P. Brennan as attorney-in-fact for Ilan Ganot
Issuer symbol
SLDB
Transactions as of
27 Jan 2022
Net transactions value
$0
Form type
4
Filing time
31 Jan 2022, 16:32:54 UTC
Next filing
08 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLDB Employee Stock Option (Right to Buy) Award $0 +466,000 $0.000000 466,000 27 Jan 2022 Common Stock 466,000 $1.13 Direct F1
transaction SLDB Restricted Stock Units Award $0 +233,000 $0.000000 233,000 27 Jan 2022 Common Stock 233,000 Direct F2, F3
transaction SLDB Employee Stock Option (Right to Buy) Award $0 +46,400 $0.000000 46,400 27 Jan 2022 Common Stock 46,400 $1.13 Wife F1
transaction SLDB Restricted Stock Units Award $0 +23,300 $0.000000 23,300 27 Jan 2022 Common Stock 23,300 Wife F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on January 27, 2022 and vests in four equal annual installments on the anniversary of the grant date.
F2 Each restricted stock unit represents a contingent right to receive one share of the Issuers common stock.
F3 The restricted stock units were granted on January 27, 2022 and vest on the same schedule as set forth in footnote (1) above.